Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vistakon Pharmaceuticals LlcfiledCriticalVistakon Pharmaceuticals Llc
Publication of AR111697A2publicationCriticalpatent/AR111697A2/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Composiciones, kits y métodos para el tratamiento o prevención de las alergias e inflamación oculares y los síntomas de las mismas, que comprenden alcaftadina o una sal farmacéuticamente aceptable de la misma.Compositions, kits and methods for the treatment or prevention of eye allergies and inflammation and the symptoms thereof, which comprise alkaltadine or a pharmaceutically acceptable salt thereof.
ARP180101296A2006-03-312018-05-16
OPHTHALM COMPOSITION FOR THE TREATMENT OF EYE ALLERGIES
AR111697A2
(en)
Compounds derived from piperidino-dihydrothienopyrimidines; pde4 inhibitors; pharmaceutical composition comprising them; and use in the treatment of disorders or diseases of the respiratory or gastrointestinal routes, as well as inflammatory diseases of the joints or eyes, among others.
COMPOUNDS DERIVED FROM PYRIMIDINS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND FOR THE TREATMENT OF ALLERGIC DISORDERS, AUTOIMMUNES, INFLAMMATORY DISEASES.
Compounds derived from substituted aromatic heterobicycles, py3 kinase inhibitors; pharmaceutical composition; Useful in the treatment of cancer, melanomas, glioblastomas, among other diseases.
Ophthalmic pharmaceutical composition comprising povidone iodine, and a steroidal anti-inflammatory compound, a non-steroidal anti-inflammatory compound, an antibacterial, an anti-allergic or an anti-glaucoma compound; and method to preserve the composition.
PHARMACEUTICAL COMPOSITIONS THAT INCLUDE A COMBINATION OF RAPAMYCIN OR ITS DERIVATIVE AND PIMECROLIMUS FOR THE TREATMENT OF INFLAMMATORY AND IMMUNOLOGICALLY MEDIATED DISEASES